Atorvastatin and almonertinib-induced myopathy in a polypharmacy context: a case report - Top-Institutions - MDSpire

Atorvastatin and almonertinib-induced myopathy in a polypharmacy context: a case report

  • By

  • Jifang Zhou

  • Lixia Yu

  • Huimin Xu

  • May 14, 2026

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, MA

    Key Differentiators

    • Neurology
  • #2

    Turku University Hospital
    Turku University Hospital

    Turku, Finland

    Key Differentiators

    • Neurology
  • #3

    neuropathology laboratory in Gothenburg
    neuropathology laboratory in Gothenburg

    Gothenburg, Sweden

    Key Differentiators

    • Neurology
  • #4

    neuromuscular center in Gothenburg
    neuromuscular center in Gothenburg

    Gothenburg, Sweden

    Key Differentiators

    • Neurology
  • #5

    Peking University First Hospital
    Peking University First Hospital

    Beijing, China

    Key Differentiators

    • Neurology

Original Source(s)

Related Content